ЕФЕКТИВНІСТЬ ІМУНОСТИМУЛЯТОРІВ ПРИ ЛІКУВАННІ КОТІВ, ХВОРИХ НА ГЕРПЕСВІРУСНИЙ РИНОТРАХЕЇТ

R.V. Petrov; O.I. Reshetylo; G.A. Zon; O.S. Kysterna; Y.O. Reshetylo

doi:10.32782/bsnau.vet.2023.1.12

R.V. Petrov https://orcid.org/0000-0001-6252-7965
O.I. Reshetylo https://orcid.org/0000-0002-5167-3622
G.A. Zon https://orcid.org/0000-0001-8205-4149
O.S. Kysterna https://orcid.org/0000-0003-4010-6101
Y.O. Reshetylo https://orcid.org/0009-0004-4447-4600

DOI: https://doi.org/10.32782/bsnau.vet.2023.1.12

Keywords: viral diseases, virological studies, diagnostics, immune correction, diseases of small animals

Abstract

The article presents data on the spread of herpesvirus rhinotracheitis in cats in the city of Sumy in the central district and nearby areas of the city. As a result of the research, it was established that herpesvirus rhinotracheitis of cats is widespread and regular cases of the disease are registered in the "Vetservice" veterinary clinic. Pedigree, age-related features of the course of the disease and seasonality of herpesvirus rhinotracheitis in cats were determined. The diagnosis of herpesvirus rhinotracheitis was established based on comprehensive epizootological, clinical, patho-anatomical data, at the same time herpesvirus rhinotracheitis was differentiated from the following diseases: calicivirus infection, chlamydia, bordetellosis Herpesviral rhinotracheitis of cats is quite often registered in Sumy: yes, in 2019, the number of registered cases of herpesviral rhinotracheitis in cats was 101, in 2020 – 127, in 2021 – 114, and in 2022 – 129. Herpesviral rhinotracheitis was more common in cats aged 1 -8 years - in 283 cases (60.1%), kittens under 6 months of age were less often sick - 99 cases (21.0%) and young cats aged 6-12 months - 52 cases (11.0%). It has been proven that cats older than 8 years were rarely sick - 37 cases (7.9%). When analyzing the breed component, it was established that purebred cats and mixed breeds were most often sick - 351 cases, which is 74.5%, British cats were less often sick - 25 cases (5.3%), Don Sphynx cats - 13 cases (2.8 %), Persian cats – 35 cases (7.4%), Siamese – 12 cases (2.5%), Scottish Fold – 28 cases (5.9%), Russian blue – 7 cases (1.5%). Immunostimulants "Imunofan" and "Fosprenil" were used when developing treatment schemes for cats from herpesvirus rhinotracheitis. The use of immunostimulant "Imunofan" in combination with "CAT-PROTECT 4", means of symptomatic therapy and the antibiotic "Cobactan" is experimentally the most effective scheme for the treatment of cats suffering from herpesvirus rhinotracheitis.

References

1. Becker, A.S., Monteiro, F.L., Scariot, A.C.A., Chagas, D.B., Fischer, G., Lima, M.d., Hübner, S.O. (2020). High occurrence of felid alphaherpesvirus 1 and feline calicivirus in domestic cats from southern Brazil. Pesquisa Veterinária Brasileira. 40:685–689. doi: 10.1590/1678-5150-pvb-6641.
2. Bergmann, M., Speck, S., Rieger, A., Truyen, U., Hartmann, K. (2020). Antibody response to feline herpesvirus-1 vaccination in healthy adult cats. J. Feline Med. Surg. 22:329–338. doi: 10.1177/1098612X19845702.
3. Bol, S. & Bunnik, E.M. (2015). Lysine supplementation is not effective for the prevention or treatment of feline herpesvirus 1 infection in cats: A systematic review. BMC Vet. Res. 11:1–15. doi: 10.1186/s12917-015-0594-3.
4. Burgesser, K.M., Hotaling, S., Schiebel, A., Ashbaugh, S.E., Roberts, S.M., Collins, J.K. (1999). Comparison of PCR, virus isolation, and indirect fluorescent antibody staining in the detection of naturally occurring feline herpesvirus infections. J. Vet. Diagn. Investig. 11:122–126. doi: 10.1177/104063879901100203.
5. Chvala-Mannsberger, S., Bago, Z., Weissenböck, H. (2009). Occurrence, morphological characterization and antigen localization of felid herpesvirus-induced pneumonia in cats: A retrospective study (2000–2006) J. Comp. Pathol. 141:163–169. doi: 10.1016/j.jcpa.2009.04.008
6. Gaskell, R., Dawson, S., Radford, A., Thiry, E. (2007). Feline herpesvirus. Vet. Res. 38:337–354. doi: 10.1051/vetres:2006063.
7. Gould D. (2011). Feline herpesvirus-1: ocular manifestations, diagnosis and treatment options. J Feline Med Surg 13(5):333–346. 10.1016/j.jfms.2011.03.010
8. Henzel, A., Brum, M.C.S., Lautert, C., Martins, M., Lovato, L.T., Weiblen R. (2012). Isolation and identification of feline calicivirus and feline herpesvirus in Southern Brazil. Braz. J. Microbiol. 43:560–568. doi: 10.1590/S1517-83822012000200017.
9. Holst, B.S., Berndtsson, L.T., Englund, L. (2005). Isolation of feline herpesvirus-1 and feline calicivirus from healthy cats in Swedish breeding catteries. J. Feline Med. Surg.7:325–331. doi: 10.1016/j.jfms.2005.03.002.
10. Horimoto, T., Limcumpao, J., Xuan, X., Ono M., Maeda, K., Kawaguchi, Y., Kai, C., Takahashi, E., Mikami, T. (1992). Heterogeneity of feline herpesvirus type 1 strains. Arch. Virol. 126:283–292. doi: 10.1007/BF01309701.
11. Lee, Y., Maes, R.K., Kruger, J.M., Kiupel, M., Giessler, K.S., Soboll Hussey, G. (2021). Safety and efficacy of felid herpesvirus-1 deletion mutants in cats. Viruses. 13:163. doi: 10.3390/v13020163.
12. Lewin, A.C., Kolb, A.W., McLellan, G.J., Bentley, E., Bernard, K.A., Newbury, S.P., Brandt, C.R. (2018). Genomic, recombinational and phylogenetic characterization of global feline herpesvirus 1 isolates. Virology. 518:385–397. doi: 10.1016/j.virol.2018.03.018.
13. Macías, P. & Navarro, C. (2018). Molecular detection of feline herpesvirus by means polymerase chain reaction. Dairy Vet. Sci. J. 8:555736.
14. Maeda, K., Horimoto, T. & Mikami, T. (1998). Properties and functions of feline herpesvirus type 1 glycoproteins. J. Vet. Med. Sci. 60:881–888. doi: 10.1292/jvms.60.881.
15. Maes, R. (2012). Felid herpesvirus type 1 infection in cats: A natural host model for alphaherpesvirus pathogenesis. ISRN Vet. Sci. 2012:1–15. doi: 10.5402/2012/495830.
16. Maggs, D.J. & Clarke, H.E. (2005). Relative sensitivity of polymerase chain reaction assays used for detection of feline herpesvirus type 1 DNA in clinical samples and commercial vaccines. Am. J. Vet. Res. 66:1550–1555. doi: 10.2460/ajvr.2005.66.1550.
17. Maggs, D.J. (2005). Update on pathogenesis, diagnosis, and treatment of feline herpesvirus type 1. Clin. Tech. Small Anim. Pract. 20:94–101. doi: 10.1053/j.ctsap.2004.12.013.
18. Monne Rodriguez, J.M., Leeming, G., Köhler, K., Kipar, A. (2017). Feline herpesvirus pneumonia: Investigations into the pathogenesis. Vet. Pathol. 54:922–932. doi: 10.1177/0300985817720982.
19. Nasisse, M.P., Guy, J.S., Davidson, M.G., Sussman, W.A., Fairley, N.M. (1989). Experimental ocular herpesvirus-infection in the cat—sites of virus-replication, clinical-features and effects of corticosteroid administration. Investig Ophthalmol Vis Sci 30(8):1758–1768
20. Richards, J.R., Elston, T.H., Ford, R.B., et al. (2006). The 2006 American association of feline practitioners Feline Vaccine Advisory Panel report. Journal of the American Veterinary Medical Association. 229(9):1405–1441.
21. Sandmeyer, L.S., Waldner, C.L., Bauer, B.S., Wen, X., Bienzle, D. (2010). Comparison of polymerase chain reaction tests for diagnosis of feline herpesvirus, Chlamydophila Felis, and Mycoplasma spp. infection in cats with ocular disease in Canada. Can. Vet. J. 51:629.
22. Sebbag, L, Thomasy, S.M., Woodward, A.P., Knych, H.K., Maggs, D.J. (2016). Pharmacokinetic modeling of penciclovir and BRL42359 in the plasma and tears of healthy cats to optimize dosage recommendations for oral administration of famciclovir. Am J Vet Res 77(8):833–845. 10.2460/ajvr.77.8.833
23. Snoeck, R. (2000). Antiviral therapy of herpes simplex. International Journal of Antimicrobial Agents. 16(2):157–159.
24. Stiles, J (2003). Feline herpesvirus. Clin Tech Small Anim Pract 18(3):178–185. 10.1053/svms.2003.ysvms28
25. Tai, S.S., Niikura, M., Cheng, H.H., Kruger, J.M., Wise, A.G., Maes, R.K. (2010). Complete genomic sequence and an infectious BAC clone of feline herpesvirus-1 (FHV-1) Virology. 401:215–227. doi: 10.1016/j.virol.2010.02.021.
26. Thomasy, S.M., Shull, O., Outerbridge, C.A., Lim, C.C., Freeman, K.S., Strom A.R., Kass, P.H., Maggs, D.J. (2016). Oral administration of famciclovir for treatment of spontaneous ocular, respiratory, or dermatologic disease attributed to feline herpesvirus type 1: 59 cases (2006–2013). J Am Vet Med Assoc 249(5):526–538. 10.2460/javma.249.5.526
27. Townsend, W.M., Jacobi, S., Tai, S.-H., Kiupel, M., Wise, A.G., Maes, R.K. (2013). Ocular and neural distribution of feline herpesvirus-1 during active and latent experimental infection in cats. BMC Vet. Res. 9:1–9. doi: 10.1186/1746-6148-9-185.
28. Wieliczko A., Płoneczka-Janeczko K. (2010). Feline herpesvirus 1 and Chlamydophila Felis prevalence in cats with chronic conjunctivitis. Pol. J. Vet. Sci. 13:381–383.
29. Yang, D.-K., Kim, H.-H., Park, Y.-R., Yoo, J.Y., Choi, S.-S., Park, Y., An, S., Park, J., Kim, J., Kim, H.-J. (2020). Isolation and molecular characterization of feline herpesvirus 1 from naturally infected Korean cats. J. Bacteriol. Virol. 50:263–272. doi: 10.4167/jbv.2020.50.4.263
30. Zicola, A., Saegerman, C., Quatpers, D., Viandier, J., Thiry, E. (2009). Feline herpesvirus 1 and feline calicivirus infections in a heterogeneous cat population of a rescue shelter. J. Feline Med. Surg.11:1023–1027. doi: 10.1016/j.jfms.2009.05.023.

EFFECTIVENESS OF IMMUNOSTIMUTANTS IN THE TREATMENT OF CATS SICK OF HERPESVIRUS RHINOTRACHEITIS

Abstract

References